Depression is associated with disconnection of neurotransmitter-related nuclei in multiple sclerosis

Mult Scler. 2021 Jun;27(7):1102-1111. doi: 10.1177/1352458520948214. Epub 2020 Sep 10.

Abstract

Background: Depression is frequently associated with multiple sclerosis (MS). However, the biological background underlying such association is poorly understood.

Objective: Investigating the functional connections of neurotransmitter-related brainstem nuclei, along with their relationship with white matter (WM) microstructure, in MS patients with depressive symptomatology (MS-D) and without depressive symptomatology (MS-nD).

Methods: Combined resting-state functional magnetic resonance imaging (fMRI) and diffusion-weighted MRI (dMRI) study on 50 MS patients, including 19 MS-D and 31 MS-nD patients, along with 37 healthy controls (HC). Main analyses performed are (1) comparison between groups of raphe nuclei (RN)-related functional connectivity (FC); (2) correlation between RN-related FC and whole brain dMRI-derived fractional anisotropy (FA) map; and (3) comparison between groups of FA in the RN-related WM area.

Results: (1) RN-related FC was reduced in MS-D when compared to MS-nD and HC; (2) RN-related FC positively correlated with FA in a WM cluster mainly encompassing thalamic/basal ganglia regions, including the fornix; and (3) FA in such WM area was reduced in MS-D.

Conclusion: Depressive symptomatology in MS is specifically associated to a functional disconnection of neurotransmitter-related nuclei, which in turn may be traced to a distinct spatial pattern of WM alterations mainly involving the limbic network.

Keywords: Multiple sclerosis; depression; functional connectivity; raphe nuclei; ventral tegmental area; white matter.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / diagnostic imaging
  • Depression / etiology
  • Humans
  • Magnetic Resonance Imaging
  • Multiple Sclerosis* / diagnostic imaging
  • Neurotransmitter Agents
  • White Matter* / diagnostic imaging

Substances

  • Neurotransmitter Agents